EPO and neoplasm: Studies using this antibody have indicated that many tumour cell lines express low-to-undetectable levels of EpoR and that any EpoR present is not functional (exposure of the cell lines to Epo does not activate signalling molecules such as STAT5 that function downstream of EpoR) (Swift et al, 2010).